Profile data is unavailable for this security.
About the company
Dr. Lal PathLabs Limited is an India-based provider of diagnostic and related healthcare tests and services in India. The Company offers patients and healthcare providers a range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its tests include Pregnancy Test, Full Body Checkups, Covid 19 Test, Heart Test, Kidney Test, Liver Test, CBC Test, Cholesterol Test, Hepatitis B Test, Kidney Function Test, Liver Function Test, Sugar Test, Thyroid Test, Typhoid Test, Uric Acid Test, Vitamin B12 Test and Vitamin D Test. The Company has approximately 280 clinical laboratories (including National Reference Lab at Delhi, Regional Reference Lab at Kolkata, Bangalore and Mumbai), 5,762 patient service centers (PSCs) and 11,619 pick-up points (PUPs). Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
- Revenue in INR (TTM)22.27bn
- Net income in INR3.58bn
- Incorporated1995
- Employees4.10k
- LocationDr. Lal PathLabs Ltd12th FloorTower B, SAS Tower, Sector 38, MedicityGURGAON 122001IndiaIND
- Phone+91 1 243016500
- Fax+91 1 244234468
- Websitehttps://www.lalpathlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare Global Enterprises Ltd | 19.08bn | 481.40m | 54.50bn | 5.50k | 114.07 | 6.60 | 25.27 | 2.86 | 3.43 | 3.43 | 136.12 | 59.29 | 0.7596 | 21.96 | 6.40 | -- | 1.65 | -2.26 | 2.26 | -3.05 | 53.40 | 53.78 | 2.17 | -3.50 | 0.8568 | 1.39 | 0.5956 | -- | 12.80 | 14.35 | 64.03 | -- | 0.0453 | -- |
| Jupiter Life Line Hospitals Ltd | 10.70bn | 1.77bn | 81.31bn | 3.14k | 43.29 | 6.96 | 37.13 | 7.60 | 28.65 | 28.65 | 171.06 | 178.30 | 0.9436 | 9.39 | 20.79 | -- | 15.58 | -- | 17.39 | -- | 82.28 | -- | 16.51 | -- | 3.67 | 7.43 | 0.00 | -- | 19.83 | -- | 142.25 | -- | -- | -- |
| Vijaya Diagnostic Centre Ltd | 5.48bn | 1.19bn | 81.35bn | 2.00k | 68.46 | 12.36 | 46.05 | 14.85 | 11.59 | 11.59 | 53.44 | 64.21 | 0.5967 | 18.10 | 42.58 | -- | 13.03 | 14.10 | 14.14 | 15.54 | 88.05 | 86.41 | 21.84 | 21.20 | 2.83 | 6.83 | 0.282 | 6.66 | 19.34 | 13.37 | 40.40 | 20.97 | 7.58 | -- |
| Metropolis Healthcare Ltd | 12.08bn | 1.28bn | 100.32bn | 4.29k | 78.71 | 9.15 | 45.00 | 8.31 | 24.88 | 24.88 | 235.10 | 213.97 | 0.7902 | 6.15 | 9.73 | -- | 8.40 | 13.65 | 10.11 | 16.94 | 78.79 | 75.73 | 10.64 | 14.66 | 1.13 | 8.35 | 0.152 | -- | 5.18 | 9.67 | -10.54 | 1.25 | 21.84 | -- |
| Rainbow Children's Medicare Ltd | 12.97bn | 2.17bn | 132.96bn | 3.58k | 61.27 | 10.56 | 40.25 | 10.25 | 21.38 | 21.38 | 127.78 | 124.03 | 0.6581 | 7.73 | 21.29 | -- | 11.08 | 9.89 | 11.99 | 10.96 | 87.26 | 83.51 | 16.83 | 13.80 | 4.00 | 5.36 | 0.377 | -- | 10.51 | 19.03 | 2.93 | 37.23 | 32.22 | -- |
| Krishna Institute Of Medical Sciencs Ltd | 24.98bn | 3.10bn | 162.99bn | 10.00k | 52.55 | 8.91 | 33.77 | 6.52 | 38.76 | 38.76 | 312.20 | 228.46 | 0.7355 | 11.49 | 9.13 | -- | 9.90 | 13.71 | 12.20 | 16.73 | 78.77 | 61.42 | 13.46 | 15.53 | 1.10 | 10.44 | 0.393 | -- | 13.67 | 22.17 | -7.78 | -- | 52.94 | -- |
| Aster DM Healthcare Ltd | 84.60bn | 293.50m | 178.25bn | 24.65k | 609.61 | 3.91 | 28.74 | 2.11 | 0.5874 | 2.60 | 170.48 | 91.60 | 0.5147 | 4.81 | 6.58 | -- | 0.6792 | 2.24 | 1.39 | 3.60 | 59.78 | 60.17 | 1.32 | 4.26 | 1.25 | 1.87 | 0.2157 | -- | 23.54 | -14.22 | 12.28 | -18.15 | 6.87 | -- |
| Dr. Lal PathLabs Ltd | 22.27bn | 3.58bn | 228.86bn | 4.10k | 63.99 | 12.38 | 45.24 | 10.28 | 42.98 | 42.98 | 267.51 | 222.23 | 0.9198 | 12.70 | 30.04 | 5,432,157.00 | 14.97 | 15.49 | 18.88 | 19.38 | 79.73 | 76.13 | 16.27 | 15.99 | 2.34 | 15.86 | 0.1158 | 23.86 | 10.40 | 13.10 | 49.78 | 12.43 | 6.44 | 31.95 |
| Narayana Hrudayalaya Ltd | 50.22bn | 7.89bn | 251.30bn | 11.73k | 31.83 | 8.71 | 24.36 | 5.00 | 38.87 | 38.87 | 247.31 | 141.98 | 1.03 | 21.58 | 11.77 | -- | 16.14 | 10.79 | 20.55 | 13.97 | 61.00 | 49.83 | 15.72 | 9.72 | 1.65 | 9.39 | 0.3605 | -- | 10.91 | 11.89 | 30.19 | 67.89 | 45.27 | 31.95 |
| Fortis Healthcare Ltd | 68.93bn | 5.99bn | 379.18bn | 2.98k | 63.34 | 4.95 | 38.39 | 5.50 | 7.93 | 7.93 | 91.26 | 101.50 | 0.536 | 14.06 | 11.40 | -- | 5.02 | 3.54 | 6.66 | 4.57 | 76.52 | 73.87 | 9.36 | 7.63 | 0.4142 | 7.62 | 0.1189 | -- | 9.45 | 9.05 | 1.72 | -- | 62.52 | -- |
| Abbott India Ltd | 58.49bn | 12.01bn | 583.61bn | 3.70k | 48.59 | 15.78 | 45.87 | 9.98 | 565.28 | 565.28 | 2,752.43 | 1,740.71 | 1.20 | 5.08 | 18.39 | -- | 24.64 | 20.92 | 33.37 | 28.59 | 44.94 | 44.32 | 20.54 | 17.26 | 1.96 | 111.00 | 0.022 | 48.29 | 9.35 | 9.72 | 26.52 | 21.68 | 31.08 | 52.32 |
Data as of Jun 14 2024. Currency figures normalised to Dr. Lal PathLabs Ltd's reporting currency: Indian Rupee INR
20.89%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invesco Advisers, Inc.as of 30 Apr 2024 | 3.47m | 4.15% |
| Wasatch Advisors LPas of 31 Mar 2024 | 2.65m | 3.18% |
| UTI Asset Management Co. Ltd. (Investment Management)as of 30 Jun 2023 | 2.34m | 2.80% |
| HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 May 2024 | 2.01m | 2.40% |
| First Sentier Investors (Australia) IM Ltd.as of 29 Feb 2024 | 1.49m | 1.78% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 1.32m | 1.58% |
| Life Insurance Corporation of India (Investment Portfolio)as of 30 Jun 2023 | 1.23m | 1.48% |
| JPMorgan Asset Management (Asia Pacific) Ltd.as of 30 Apr 2024 | 1.03m | 1.24% |
| First Sentier Investors (Singapore)as of 29 Feb 2024 | 952.63k | 1.14% |
| First Sentier Investors (Hong Kong) Ltd.as of 30 Jun 2023 | 952.63k | 1.14% |
More ▼
Data from 31 Mar 2024 - 12 Jun 2024Source: FactSet Research Systems Inc.
